TY - JOUR
T1 - The consecutive impact of COVID-19 on thoracic surgical procedures in Japan
T2 - an analysis of data from the National Clinical Database
AU - Sato, Yukio
AU - Yamamoto, Hiroyuki
AU - Ikeda, Norihiko
AU - Konishi, Hiroshi
AU - Hibi, Taizo
AU - Endo, Shunsuke
AU - Inoue, Masayoshi
AU - Okada, Yoshinori
AU - Shintani, Yashushi
AU - Toyooka, Shinichi
AU - Nakamura, Hiroshige
AU - Hoshikawa, Yasushi
AU - Chen-Yoshikawa, Toyofumi Fengshi
AU - Uramoto, Hidetaka
AU - Tsubochi, Yoshihiro
AU - Kakizoe, Tadao
AU - Chida, Masayuki
AU - Yoshino, Ichiro
N1 - Publisher Copyright:
© The Author(s) under exclusive licence to Springer Nature Singapore Pte Ltd. 2023.
PY - 2024/6
Y1 - 2024/6
N2 - Purpose: The current study was designed to analyze the impact of the COVID-19 pandemic on general thoracic surgeries in Japan. Methods: Changes in surgeries for lung cancer and metastatic lung tumors were evaluated based on National Clinical Database data regarding cancer screening. Results: In 2021, surgeries for primary lung cancer increased by 3.4% compared to 2020, which, given the increase from 2014 to 2019, indicates an overall 11.1% decrease. In contrast, surgeries for metastatic lung tumors in 2021 decreased by 5.8% compared to 2020, which, given the increase from 2014 to 2020, indicates an overall 9.2% decrease. Half of the primary diseases for metastatic lung tumor were cases of colorectal cancer. Low anterior resection procedures in 2020 decreased by 5.5% compared to 2019. Lung and colon cancer screening examinees in 2021 were increased compared to 2020; however, they still showed respective decreases of 11% and 9.0% compared to 2019. Conclusions: Surgeries for primary lung cancer still decreased substantially during the COVID-19 pandemic. The continued stagnation of screening was responsible for this decrease. Surgeries for metastatic lung tumors decreased profoundly, and the decrease in screening for primary tumors was responsible for this reduction. Our findings emphasize the significance of maintaining cancer screening efforts, even during a pandemic.
AB - Purpose: The current study was designed to analyze the impact of the COVID-19 pandemic on general thoracic surgeries in Japan. Methods: Changes in surgeries for lung cancer and metastatic lung tumors were evaluated based on National Clinical Database data regarding cancer screening. Results: In 2021, surgeries for primary lung cancer increased by 3.4% compared to 2020, which, given the increase from 2014 to 2019, indicates an overall 11.1% decrease. In contrast, surgeries for metastatic lung tumors in 2021 decreased by 5.8% compared to 2020, which, given the increase from 2014 to 2020, indicates an overall 9.2% decrease. Half of the primary diseases for metastatic lung tumor were cases of colorectal cancer. Low anterior resection procedures in 2020 decreased by 5.5% compared to 2019. Lung and colon cancer screening examinees in 2021 were increased compared to 2020; however, they still showed respective decreases of 11% and 9.0% compared to 2019. Conclusions: Surgeries for primary lung cancer still decreased substantially during the COVID-19 pandemic. The continued stagnation of screening was responsible for this decrease. Surgeries for metastatic lung tumors decreased profoundly, and the decrease in screening for primary tumors was responsible for this reduction. Our findings emphasize the significance of maintaining cancer screening efforts, even during a pandemic.
KW - COVID-19
KW - Lung cancer
KW - Lung cancer screening
KW - Metastatic lung tumor
UR - http://www.scopus.com/inward/record.url?scp=85176005041&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85176005041&partnerID=8YFLogxK
U2 - 10.1007/s00595-023-02763-0
DO - 10.1007/s00595-023-02763-0
M3 - Article
C2 - 37934307
AN - SCOPUS:85176005041
SN - 0941-1291
VL - 54
SP - 627
EP - 633
JO - Surgery Today
JF - Surgery Today
IS - 6
ER -
